NPR News·3 min read·medium
What would it take to get peptides on the shelf?
W
Will Stone
✦AI Summary
An FDA advisory panel has recommended allowing the production of several peptide therapies, though they remain illegal for compounding pharmacies to manufacture currently. The regulatory process for potential approval is expected to be lengthy, leaving patients in a state of uncertainty.
The peptide saga has reached what could be its most confusing chapter — at least for consumers.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in